It has been suggested that loss of expression of the gene has prognostic implications for melanoma (Behrmann et al.,2003) and codeletion of MTAP with CDKN2A has been investigated in a number of cancers (Chen et al.,1996). This evidence concerns the gene CDKN2A and melanoma.